Recent studies have demonstrated that ACSL4-dependent ferroptosis signaling contributes significantly to disease progression in diabetic cardiomyopathy [49, 50], nephropathy [51], and retinopathy [52]. Here, ACSL4 is linked to diabetic cardiomyopathy.